Phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC)

被引：0
|
作者：
Wang, T. [1 ]
Jiang, Z. [1 ]
Song, S. [1 ]
Shen, G. [1 ]
Zhang, S. [1 ]
Wu, S. [1 ]
Zeng, M. [1 ]
机构：
[1] 307 Hosp Affiliated, Mil Med Acad, Ctr Canc, Beijing, Peoples R China
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [21] Pegylated liposomal doxorubicin (PLD) and gemcitabine (G) in metastatic breast cancer (MBC) patients: A phase II study.
    Fabi, A
    Papaldo, P
    Ciccarese, M
    Salesi, N
    Lorusso, V
    Ferretti, G
    Carlini, P
    Sacchi, I
    Cecere, F
    Cognetti, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 80S - 80S
  • [22] Gemcitabine and capecitabine in metastatic breast cancer (MBC): A Brown University Oncology Group (BrUOG) phase II study.
    Sikov, WM
    Theall, KP
    Seidler, CW
    Strenger, RS
    Fenton, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 74S - 74S
  • [23] A phase II study of a combination of pemetrexed (Pem) and gemcitabine (Gem) in patients with metastatic breast cancer (MBC): An NCCTG study.
    Ma, CX
    Steen, P
    Rowland, KM
    Niedringhaus, RD
    Kugler, JW
    Ingle, JN
    Perez, EA
    Adjei, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 36S - 36S
  • [24] A phase II study of vinorelbine (VNR) and letrozole (LTZ) in aged women with metastatic breast cancer (MBC).
    Manga, GP
    Bueno, JMG
    Palombo, H
    Morales, S
    Méndez, M
    Esteban, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 65S - 65S
  • [25] Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
    J Millar
    P Scullin
    A Morrison
    B McClory
    L Wall
    D Cameron
    H Philips
    A Price
    D Dunlop
    M Eatock
    British Journal of Cancer, 2005, 93 : 1112 - 1116
  • [26] Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
    Millar, J
    Scullin, P
    Morrison, A
    McClory, B
    Wall, L
    Cameron, D
    Philips, H
    Price, A
    Dunlop, D
    Eatock, M
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1112 - 1116
  • [27] Phase II trial of biweekly gemcitabine, paclitaxel, and bevacizumab as frontline therapy for metastatic breast cancer (MBC)
    Nahleh, Z. A.
    Gupta, R.
    Abrams, J.
    Gartner, E. M.
    Reichle, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] A phase II trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC).
    Bensalem, A
    Bouzid, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 72S - 72S
  • [29] Gemcitabine and cisplatin in metastatic breast cancer
    Moura, G. L.
    Pasquini, R.
    Frare, A.
    Vianna, K.
    Albini, L.
    Padilha, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Gemcitabine plus cisplatin in patients with locally advanced or metastatic breast cancer (MBC) who failed prior anthracycline therapy ± taxanes.
    El Khodary, A
    Gouda, Y
    Al Noweim, S
    Kohail, H
    Gaafar, R
    Zawahry, H
    Wareth, AA
    Mansour, O
    Shehata, S
    Hamid, TA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 69S - 69S
12345